"As we thoroughly collate and evaluate three years of studying GLP-1 obesity drug trends among real-world populations, new patterns are emerging that help us understand how these drugs are being used and how external factors may be impacting persistence and health outcomes," said Pat Gleason, PharmD, assistant vice president, health outcomes, at Prime
But then in 2021 [semaglutide] became approved for weight loss
If your symptoms are severe, persistent, or accompanied by other symptoms like belly pain, contact your healthcare provider
Some patients may experience symptoms such as nausea, vomiting, diarrhea, and constipation
Ozempic is the brand name for semaglutide , a prescription GLP-1 receptor agonist used primarily to treat type 2 diabetes
Int J Food Sci Nutr